Acute Retinal Detachment Repair With the iSeelr™ Retinal Detachment Repair System
Recruiting
N/A
Interventional Study
Rhegmatogenous Retinal Detachment - Macula Off
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 10 (estimated)
- Sponsor
- Photofuse Pty Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a first-in-human clinical trial testing a new treatment for rhegmatogenous retinal detachments. The new treatment called retinal thermofusion uses a special laser device called iSeelr™ during surgery. The benefit of the device is that it repairs retinal tears without needing a gas bubble making it quicker to recover from surgery. The study will help us determine how safe and well the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged 50 years or older.
* Willing and able to comply with all study requirements and visits.
* Provided written informed consent.
Study Eye:
* Recent onset as demonstrated by symptoms or diagnosis macular involving rhegmatogenous retinal detachment.
* Detachment due to singl…
Contacts